Themis Medicare
Themis Medicare Performance
Day Range
- Low 178.40
- High 184.60
52 Week Range
- Low 106.06
- High 197.17
- Open Price182.00
- Previous Close181.85
- Volume34365
Start SIP in Themis Medicare
Start SIPThemis Medicare Investment Rating
-
Master Rating:
-
Themis Medicare has an operating revenue of Rs. 370.32 Cr. on a trailing 12-month basis. An annual revenue de-growth of -9% needs improvement, Pre-tax margin of 17% is great, ROE of 16% is good. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 9% and 26% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 66 which is FAIR indicating the recent price performance, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 68 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Institutional holding has remained stable in the last reported quarter. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
|---|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 105 | 97 | 80 | 89 | 91 | 94 | 80 |
| Operating Expenses Qtr Cr | 92 | 75 | 70 | 74 | 70 | 74 | 65 |
| Operating Profit Qtr Cr | 12 | 22 | 10 | 15 | 21 | 20 | 14 |
| Depreciation Qtr Cr | 3 | 3 | 3 | 3 | 3 | 2 | 2 |
| Interest Qtr Cr | 2 | 2 | 3 | 2 | 2 | 2 | 2 |
| Tax Qtr Cr | 3 | 4 | 2 | 4 | 5 | 5 | 4 |
| Net Profit Qtr Cr | 7 | 13 | 6 | 12 | 14 | 12 | 8 |
Themis Medicare Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 14
- Bearish Moving Average
- ___
- 2
- 20 Day
- ₹170.02
- 50 Day
- ₹165.80
- 100 Day
- ₹161.52
- 200 Day
- ₹150.82
- 20 Day
- ₹166.96
- 50 Day
- ₹166.68
- 100 Day
- ₹163.41
- 200 Day
- ₹150.93
Themis Medicare Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 188.07 |
| Second Resistance | 194.28 |
| Third Resistance | 197.57 |
| RSI | 63.08 |
| MFI | 83.03 |
| MACD Single Line | 2.86 |
| MACD | 5.72 |
| Support | |
|---|---|
| First Resistance | 178.57 |
| Second Resistance | 175.28 |
| Third Resistance | 169.07 |
Themis Medicare Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 157,566 | 10,066,892 | 63.89 |
| Week | 220,084 | 12,679,016 | 57.61 |
| 1 Month | 164,398 | 9,372,346 | 57.01 |
| 6 Month | 58,175 | 3,231,639 | 55.55 |
Themis Medicare Result Highlights
Themis Medicare Synopsis
NSE-Medical-Generic Drugs
Themis Medicare Ltd. is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 354.32 Cr. and Equity Capital is Rs. 9.20 Cr. for the Year ended 31/03/2023. Themis Medicare Ltd. is a Public Limited Listed company incorporated on 31/05/1969 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24110GJ1969PLC001590 and registration number is 001590.| Market Cap | 1,677 |
| Sales | 370 |
| Shares in Float | 3.04 |
| No of funds | 3 |
| Yield | 2.8 |
| Book Value | 5.95 |
| U/D Vol ratio | 0.3 |
| LTDebt / Equity | 10 |
| Alpha | 0.24 |
| Beta | 0.95 |
Themis Medicare
| Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
|---|---|---|---|---|
| Promoters | 67.16% | 67.16% | 67.16% | 67.18% |
| Mutual Funds | ||||
| Foreign Portfolio Investors | 0.05% | 0.04% | 0.06% | 0.02% |
| Financial Institutions/ Banks | 0.01% | 0.01% | 0.01% | 0.01% |
| Individual Investors | 22.32% | 22.64% | 23.12% | 23.15% |
| Others | 10.46% | 10.15% | 9.65% | 9.64% |
Themis Medicare Management
| Name | Designation |
|---|---|
| Dr. Dinesh S Patel | Chairman & Executive Director |
| Dr. Sachin D Patel | Managing Director & CEO |
| Mr. Rajneesh Anand | Non Executive Director |
| Mr. Hariharan Subramaniam | Independent Director |
| Ms. Manjul Sandhu | Independent Director |
| Mr. Bhaskar V Iyer | Independent Director |
| Mr. Vijay G Agarwal | Independent Director |
Themis Medicare Forecast
Price Estimates
Themis Medicare Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2023-11-04 | Quarterly Results | |
| 2023-08-10 | Quarterly Results | (Revised) per share(17.5%)Final Dividend |
| 2023-05-13 | Audited Results, Dividend & Stock Split | |
| 2023-02-03 | Quarterly Results | |
| 2022-11-07 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2023-10-10 | Split | Rs.0.00 split from Rs. 10/- to Re. 1/-. |
Themis Medicare FAQs
What is Share Price of Themis Medicare ?
Themis Medicare share price is ₹179 As on 11 December, 2023 | 11:44
What is the Market Cap of Themis Medicare ?
The Market Cap of Themis Medicare is ₹1653.7 Cr As on 11 December, 2023 | 11:44
What is the P/E ratio of Themis Medicare ?
The P/E ratio of Themis Medicare is 32.3 As on 11 December, 2023 | 11:44
What is the PB ratio of Themis Medicare ?
The PB ratio of Themis Medicare is 4.9 As on 11 December, 2023 | 11:44